Is the U.S.-mandated Hepatitis B vaccine administered to newborn infants within 24 hours of birth the initial ‘impact’ vaccine for ‘programming’ a child’s unfortunate decline into the Autism Spectrum Disorder (ASD)?

The answer to that question is a resounding “YES” according to a 2016 peer review study titled, Neonatal hepatitis B vaccination impaired the behavior and neurogenesis of mice transiently in early adulthood published in the Elsevier peer review journal Psychoneuroendochrinology.

The extensive research on mice brains published above indicates what the CDC/FDA should have found and warned against as part of the licensing procedures for the Hepatitis B vaccine introduced as a recommended infant/childhood vaccine way back in 1991, when “the first dose was recommended to be administered at birth before hospital discharge or at age 1–2 months.” [3]

That apparent default by the ever-increasing-malfeasance being exposed on the part of the CDC/FDA’s either ineptness or reliance upon what’s known as “consensus science,” is proof of the absolute need for the dismantling of a federal U.S. health agency—listed on the U.S. Stock Exchange (NASDAQ) [4]—by Congress, who has oversight.

(more)